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Introduction
CD44, a cell adhesion molecule (CAM) encoded by one gene, but with >20 isoforms produced by alternative mRNA splicing and/or post-translational modifications.
1 CD44
standard (CD44s) is the most abundant isoform, expressed by most mammalian cells 2 and involved in hyaluronan uptake and degradation, 3 angiogenesis, 4 wound healing, 5 tissue formation and patterning. 2 CD44s is also a critical signaling receptor. 6 In contrast, CD44
variants (CD44v) are up-regulated in neoplasia 7 and involved in tumor metastasis 8 and aggression. 9 Via different binding domains and regulated by post-translational modifications, CD44s
binds the extracellular matrix (ECM) components hyaluronan, 10 collagen, 11 fibronectin 12 as well as transmembrane receptors such as E-selectin. 13 Among these, hyaluronan is the most common ligand. Although many cells express high levels of CD44s, they do not constitutively bind hyaluronan, with N-glycosylation 14 and carbohydrate-sulfation 15 each independently modulating binding capacity. Hyaluronan is synthesized by three hyaluronan synthases: HAS1, HAS2 and HAS3 at the inner face of the plasma membrane and extruded to the outer surface, where it is secreted. CD44 is the most common receptor for hyaluronan and hyaluronan uptake and degradation occurs in a CD44-dependent manner. [16] [17] Hyaluronan is an important component of the hematopoietic stem cell (HSC) niche, [18] [19] participating in HSC lodgment in the endosteal region as well as functioning in HSC proliferation and differentiation. Furthermore, it has been reported that CD44, hyaluronan and stromal cellderived factor-1 (SDF-1) interaction affects HSC and progenitor cell trafficking. 20 Hence,
CD44s is anticipated to be involved in hematopoietic regulation.
Previously, important roles for CD44s in adult hematopoiesis have been identified. In mice, blocking CD44s inhibits lymphopoiesis in long-term bone marrow (BM) cultures, 21 T precursor trafficking to the thymus and lymph nodes 22 and memory cell activation. 23 Furthermore, CD44s expression is down-regulated during myeloid and erythroid development 24 and involved in the retention of hematopoietic progenitors in BM and spleen. 25 Similarly, CD44s plays a role in human hematopoietic regulation, including lymphocyte migration 22, 26-27 and activation, [28] [29] [30] as well as progenitor cell proliferation and homing to BM. 31 CD44 has been shown to regulate HSC and their BM microenvironment by influencing: 1) matrix assembly; 2) cytokine/chemokine capture and/or release; 3)
cytoskeletal linker protein binding (eg. ankyrin, ezrin, radixin and moesin) and signal transduction; and 4) matrix degradation via protease production to influence HSC adhesion, homing, migration, quiescence, resistance to oxidative stress as well as mobilization. C57BL/6J and PTPRCA mice are congenic strains, genetically identical except for the CD45 locus. Therefore, when transplanted together, specific CD45.1 and CD45.2 antibodies, allow the specific contribution of each donor population to be determined. Adult mice were 6-8 weeks old and sex matched. Non-ablated recipients and WT BM carrier cells were used in homing and spatial distribution assays, while irradiated recipients and BM carrier cells were used for long-term transplants. Recipients were irradiated using a split dose (4.5Gy each), 4-5 hours apart, 24 hours prior to transplant and carrier cells exposed to a single dose of 15Gy on the day of transplant. The MARP ethics committee approved all experiments and institutional and national guidelines for the care and use of laboratory animals were followed.
Timed pregnancies were set up late afternoon and separated early the following morning with vaginal plugs designated as 0.5 days (E0.5). Pups were harvested from embryonic day 14.5 (E14.5) until newborn day 9 (D9) as previously described.
37

Hematopoietic cell isolation
Endosteally and centrally located adult BM HSC and fetal HSC (Lineage -Sca-1 + c-Kit + (LSK) CD150 + CD48 -) were isolated and analyzed as previously described. [37] [38] Cell counts were performed on a Sysmex KX-21N automated cell counter (Sysmex, Japan).
Flow cytometry
Flow cytometric analysis used a LSRII and cell sorting used an Influx (Becton Dickinson, NJ, USA) equipped as previously described. 39 HSC cells were sorted at ~20,000 cells per second and re-analyzed to confirm purity (>95%). CD44 expression was analyzed on hematopoietic stem and progenitor cells using CD44-biotin-streptavidin-V500.
Homing and spatial distribution assays
Sorted fetal liver HSC or adult BM HSC were stained with CFDA-SE (CFSE when incorporated) or SNARF at 0.5µM and 1µM respectively as previously described. 40 The homing efficiency of donor cells was determined by co-transplanting 1-3x10 3 CFSE + CD44
-/-HSC and SNARF + WT HSC with 2×10 5 unlabeled carrier cells into non-ablated recipients as previously described. 39 Homing efficiency was calculated as the number of donor HSC homed to the BM divided by the number of donor HSC transplanted, assuming one iliac crest, femur and tibia contain 15% of total BM cells. 41 A homing assay in a non-ablated mouse model [42] [43] allows for assessment in steady-state hematopoiesis, with ablation disrupting BM integrity [44] [45] and causing increased cytokine activity 46 that drives donor cells to cycle. 47 Sequential transplant spatial distribution assays were performed as previously described. 40 Specifically, irradiated WT and CD44 -/-mice were initially transplanted with either WT or CD44 -/-BM cells and allowed to reconstitute for 20 weeks (>95% chimerism). WT or CD44
-/-CFSE + LSK cells with 2×10 5 unlabeled carrier cells were then transplanted into non-ablated pre-reconstituted mice to assess their lodgment 15 hours post-transplant both via flow cytometry as well as histologically in paraffin embedded femur sections. 48 The number of cells located in the endosteal (within 12-cell diameters from the bone/BM interface in the diaphysis or in the metaphysis) and central BM regions were counted manually.
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Cell lysis and SDF-1α quantification via ELISA Whole embryonic livers were dissociated in PBS and separated into supernatant and pellet fractions by centrifugation and the pellet was lysed as previously described 39 . E16.5 fetal bones were dissected and cut with fine scissors before lysis as per the method above. SDF-1α expression was assayed in duplicates from 3 biological repeats at each time point using an ELISA kit (R&D) according to the manufacturer's instructions and normalized for total protein. (lymphoid) antibodies as previously described. 38 Mice with >1% donor multi-lineage reconstitution were designated positive.
Limiting dilution reconstitution assay
Competitive limiting dilution reconstitution assay
The 
Statistical analysis and data presentation
Flow cytometric analysis was performed using FlowJo and Sigma Plot for data comparison.
A student t-test, Mann-Whitney rank sum test, one-way ANOVA or one-way ANOVA on ranks was used to determine statistical significance as appropriate. A Kaplan Meier and logrank test were used to assess survival.
Results
HSC express CD44 throughout development, but at lower levels than progenitors. From E16.5 onwards, including during adulthood, CD44 -/-mice consistently weighed significantly less than age and sex matched WT controls (Online Supplemental Figure S1A ).
After normalizing for weight, CD44 -/-fetal liver (FL) cellularity was significantly higher at E14.5 and E16.5 (Online Supplemental Figure S1B ). In contrast, normalized fetal and adult BM as well as fetal spleen cellularities were comparable between CD44 -/-and WT mice (Online Supplemental Figure S1B ). Normalized values were used for all subsequent cell content calculations. Furthermore, lineage analysis of fetal and adult hematopoietic organs revealed no significant differences in the proportions of granulocytes (Gr-1 + in fetal 53 and Gr- Figure S1C ).
The absence of CD44 significantly alters HSC and progenitor pools in fetal and adult hematopoietic organs in a developmental age dependent manner.
The incidence and number of HSC and progenitors were assessed in the absence of CD44, providing important but different information; with a number of examples occurring where one is altered, but the other is not affected or is altered in the opposite direction due to changes in total cellularity. [54] [55] In adult BM, CD44 acts as a negative regulator with a significant increase in both the proportion and number of LSK, LSKCD150 In FL, the absence of CD44 resulted in increased frequencies and numbers of HSC ( Figure   3A ), LSK (Online Supplemental Figure S2A ) and LSKCD150 Figure S3A ) at E16.5 up until D3 post-birth. Furthermore, the increased CD44 -/-FL HSC pool was accompanied by a delayed depletion of HSC from the liver, with a HSC content of zero being detected at D2 in WT pups, in contrast to D4 in CD44 -/-pups ( Figure   3A ). Similarly to that evident in the adult, cell cycle analysis revealed no changes in E16.5
CD44 -/-FL LSK cells compared to their WT counterparts (data not shown, n=3).
In CD44 -/-pups, fetal BM had a significantly lower incidence and number of HSC from D0 to D4 ( Figure 3B ). In contrast, the absence of CD44 had limited impact on BM progenitors (LSK and LSKCD150
, with a significant difference in their content only detected at D2 (Online Supplemental Figure S2B and S3B). The absence of CD44 in the spleen resulted in a significantly lower incidence and number of HSC at D0 to D2 ( Figure 3C ). Collectively, the absence of CD44 significantly altered the HSC and progenitor pools in fetal and adult hematopoietic organs in a developmental age dependent manner.
CD44 is implicated in the migration of fetal HSC from liver to BM via changes in SDF-1α expression.
With no evident changes to cell cycle, a proliferative defect of CD44 -/-FL HSC is unlikely to explain the observed augmented HSC pools or the delayed HSC depletion in FL ( Figure 3A ).
However, the accompanying lower numbers of HSC in the BM and spleen at the same developmental ages ( Figure 3B and C) suggests CD44 is involved in fetal HSC migration. As a consequence, the absence of CD44 on the homing efficiency of fetal FL HSC was assessed.
No differences were observed between CD44 -/-and WT FL HSC homing to adult BM ( Figure   4A ), suggesting the absence of CD44 does not result in an intrinsically altered homing ability.
Alternatively, the impact on HSC migration in the absence of CD44 could be the consequence of changes in the FL microenvironment. As the CXCR4/SDF-1α pathway has been demonstrated to be important in HSC migration during development, 56 CXCR4 and SDF-1α expression was examined. Analysis of the expression of CXCR4 on CD44 -/-and WT FL HSC revealed no differences at any of the time points assessed (data not shown). In FL, SDF-1α was exclusively detected in the cellular fraction. In WT FL, the concentration of SDF-1α significantly decreased from E14.5 to E17.5. In contrast, no significant changes in FL SDF-1α concentration was evident over this period in the absence of CD44, resulting in a significantly greater amount of SDF-1α in CD44 -/-FL at E16.5 and E17.5 ( Figure 4B ).
However, analysis of the concentration of SDF-1α in E16.5 fetal bones found no difference between CD44 -/-and WT animals ( Figure 4C ). This organ and developmental age specific change in SDF-1α levels directly correlated with the delayed HSC migration from FL.
CD44 is important for adult HSC homing and lodgment.
As the presence of CD44 was important for the migration of FL HSC, a potential role in the homing of adult BM HSC was also assessed ( Figure 5A ). The presence of CD44 on both donor endosteal HSC and in the recipient microenvironment was critical for homing of endosteal HSC, with its absence from either resulting in a significant decrease in homing efficiency ( Figure 5B ). However, the presence of CD44 on donor HSC or in the microenvironment had no impact on the ability of central HSC to home to the BM ( Figure   5B ). Importantly, significantly increased homing of WT endosteal HSC into a WT animal was observed compared to the homing of HSC isolated from the central BM region ( Figure   5B ), which is in agreement with that previously published. Together, the data suggest CD44 -/-HSC have higher long-term engraftment potential than their WT counterparts.
Discussion
Previous studies showed CD44 is highly expressed on adult HSC 57 and early erythroid progenitors, but down-regulated during lineage commitment. 24 In addition, adult BM cells with colony-forming-unit granulocytes-macrophage and burst-forming unit-erythroid are predominantly found in the CD44 bright population. 58 The current analysis extended these findings to reveal CD44 expression on HSC is significantly reduced compared to that detected on progenitor cells throughout development. Furthermore, in adult BM, CD44 is expressed at a higher level on HSC isolated from the endosteal BM region compared to those isolated from the central BM. Although there is no difference in the incidence of HSC between endosteal and central BM, due to the higher total cellularity in central BM, the total number of HSC in this region is significantly higher than in the endosteal region. However, the data demonstrates CD44 functions in maintaining the HSC and progenitor pools in a developmental age and location dependent manner. In adulthood, CD44 -/-BM had significantly increased stem and progenitor cell pools. Together the data suggests CD44 acts as a negative regulator of HSC proliferation, which is potentially regulated through the CD44/hyaluronan interaction. Previously, hyaluronan was shown to be highly expressed at the endosteal BM surface as well as acting as a negative regulator of HSC proliferation. 18, 48 This could also explain why endosteal HSC have significantly higher CD44 expression compared to centrally isolated HSC. found CD44 -/-T cell progenitors showed a homing defect to the thymus and lymph nodes as well as a dysregulation of progenitor cell mobilization with a significant decrease in the number of CFU-GM in the spleen following G-CSF administration.
35
The current data extends our understanding of fetal hematopoiesis and highlights a role for CD44 in fetal HSC anchoring and migration, with a proposed model of the underpinning mechanisms described in Figure 8A . During embryogenesis, HSC initially migrate to FL before colonizing the spleen and BM later in development. Migration is essential for fetal hematopoiesis as multiple sites allow different inductive signals from the microenvironments to support hematopoietic development. 66 We show that in WT mice, FL SDF-1 concentration progressively decreased from E14.5, with HSC migrating from the FL to the BM after E16.5.
Accumulation of data in other in vivo and in vitro contexts, including the homing of HSC and progenitors to BM, 20 suggests this occurs due to a coordinated sequence of events including:
1) a polarized source of SDF-1 developing; 2) the cells producing projections extending towards the SDF-1, with cell associated CD44 migrating into the projections; and 3) CD44
binding to an external source of hyaluronan and the cells undergoing trans-endothelial migration. However, in the absence of CD44, the concentration of FL SDF-1 remained unchanged from E14.5 to E17.5 and HSC and progenitors were not released from the FL microenvironment to migrate to the BM ( Figure 8A ). This data is supported by Petit et al. 67 who demonstrated that decreased SDF-1 levels result in HSC detachment and migration from their microenvironment. The major source of SDF-1 in E15.5 mouse FL is hepatic stem/progenitor (stromal) cells 68 and it has been shown that SDF-1 -/-HSC are not retained in the FL but migrate into the PB. 56 Furthermore, genetic silencing of CD44 expressed by endothelial cells increased SDF-1 mRNA expression via NFκB. 69 This suggests the accumulation of SDF-1 in CD44 -/-FL is the direct result of the absence of CD44, with a resulting increase in HSC and progenitors that remain firmly attached to the FL 1 microenvironment, delaying their migration to the BM. Our data demonstrates that this increase in HSC and progenitors was not due to changes in cell cycle or due to an intrinsic homing defect. In addition, examination of CXCR-4 on WT and CD44 -/-FL HSC and progenitors at E16.5 revealed no differences. This finding is also in agreement with previous studies reporting that while human HSC and progenitors pre-incubated with CD44 blocking antibody had impaired homing ability in vivo as well as decreased migration towards a SDF-1 gradient in vitro, this was not due to the down-regulation of CXCR-4 expression 20 .
In summary, the current study demonstrates a number of roles of CD44 in hematopoiesis throughout development ( Figure 8B ). CD44 is highly expressed on HSC and progenitors and regulates their pools in situ. 
